Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo ; volume:8 ; number:1 ; day:2 ; month:10 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (2.10.2018), 1-10, 12.2018
- Klassifikation
-
Biowissenschaften, Biologie
- Urheber
-
Kelly, R. D. W.
- Beteiligte Personen und Organisationen
-
Chandru, A.
Watson, P. J.
Song, Y.
Blades, M.
Robertson, N. S.
Jamieson, A. G.
Schwabe, J. W. R.
Cowley, S. M.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-32927-9
- URN
-
urn:nbn:de:101:1-2018111016460819226467
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kelly, R. D. W.
- Chandru, A.
- Watson, P. J.
- Song, Y.
- Blades, M.
- Robertson, N. S.
- Jamieson, A. G.
- Schwabe, J. W. R.
- Cowley, S. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
Synthesis and Characterization of Histone Deacetylase (HDAC) Inhibitors and PROTACs
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins
Genome-scale network model of metabolism and histone acetylation reveals metabolic dependencies of histone deacetylase inhibitors
Histone deacetylase 6 in cancer
The histone deacetylase (HDAC) Rpd3 antagonizes heterochromatin formation at telomeres in Saccharomyces cerevisiae
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Jasmonates and Histone deacetylase 6 activate Arabidopsis genome-wide histone acetylation and methylation during the early acute stress response
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
Synthesis and Characterization of Histone Deacetylase (HDAC) Inhibitors and PROTACs
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins
Genome-scale network model of metabolism and histone acetylation reveals metabolic dependencies of histone deacetylase inhibitors
Histone deacetylase 6 in cancer
The histone deacetylase (HDAC) Rpd3 antagonizes heterochromatin formation at telomeres in Saccharomyces cerevisiae
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Jasmonates and Histone deacetylase 6 activate Arabidopsis genome-wide histone acetylation and methylation during the early acute stress response
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
Synthesis and Characterization of Histone Deacetylase (HDAC) Inhibitors and PROTACs
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins
Genome-scale network model of metabolism and histone acetylation reveals metabolic dependencies of histone deacetylase inhibitors
Histone deacetylase 6 in cancer
The histone deacetylase (HDAC) Rpd3 antagonizes heterochromatin formation at telomeres in Saccharomyces cerevisiae
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors